# Boost Run Inc.: financial statements, quarterly

BRUN · Nasdaq · CIK 2090646 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/brun.md) · [Financials](/companies/brun/financials.md) · [Filings](/companies/brun/filings.md) · [Insiders](/companies/brun/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/brun/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [8.4](/filings/0001493152-26-039031.md) | not reported | [31.1](/filings/0001493152-26-039031.md) |
| Cost of revenue | $m | not reported | [0.5](/filings/0001493152-26-039031.md) | not reported | [1.7](/filings/0001493152-26-039031.md) |
| Selling, general and administrative | $m | not reported | [0.8](/filings/0001493152-26-039031.md) | not reported | [13.6](/filings/0001493152-26-039031.md) |
| Operating income | $m | not reported | [3.0](/filings/0001493152-26-039031.md) | [(0.1)](/filings/0001493152-26-039029.md) | [(12.9)](/filings/0001493152-26-039031.md) |
| Interest expense | $m | not reported | [0.5](/filings/0001493152-26-039031.md) | not reported | [5.1](/filings/0001493152-26-039031.md) |
| Income tax | $m | not reported | not reported | not reported | [55.7](/filings/0001493152-26-039031.md) |
| Net income | $m | [0.0](/filings/0001493152-26-039031.md) | [2.5](/filings/0001493152-26-039031.md) | [(4.1)](/filings/0001493152-26-039031.md) | [(75.0)](/filings/0001493152-26-039031.md) |
| Diluted EPS | $ per share | not reported | not reported | [(51000.00)](/filings/0001493152-26-039029.md) | not reported |
| Basic EPS | $ per share | not reported | not reported | [(51000.00)](/filings/0001493152-26-039029.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [2.0](/filings/0001493152-26-039031.md) | [9.7](/filings/0001493152-26-039031.md) | not reported | [120](/filings/0001493152-26-039031.md) |
| Current assets | $m | not reported | not reported | not reported | [19.7](/filings/0001493152-26-039031.md) | not reported | [155](/filings/0001493152-26-039031.md) |
| Total assets | $m | not reported | not reported | not reported | [77.4](/filings/0001493152-26-039031.md) | not reported | [742](/filings/0001493152-26-039031.md) |
| Current liabilities | $m | not reported | not reported | not reported | [40.6](/filings/0001493152-26-039031.md) | not reported | [179](/filings/0001493152-26-039031.md) |
| Total liabilities | $m | not reported | not reported | not reported | [69.3](/filings/0001493152-26-039031.md) | [0.1](/filings/0001493152-26-039029.md) | [642](/filings/0001493152-26-039031.md) |
| Long-term debt | $m | not reported | not reported | not reported | [6.0](/filings/0001493152-26-039031.md) | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | [0.2](/filings/0001493152-26-039031.md) | not reported | not reported |
| Shareholders' equity | $m | [7.5](/filings/0001493152-26-039031.md) | [8.2](/filings/0001493152-26-039031.md) | [11.0](/filings/0001493152-26-039031.md) | [8.1](/filings/0001493152-26-039031.md) | [4.2](/filings/0001493152-26-039031.md) | [100](/filings/0001493152-26-039031.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Shares

| Line item | Unit | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: |
| Diluted shares (weighted) | units of shares | [1.0](/filings/0001493152-26-039029.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.